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CDP-diacylglycerol (CDP-DAG) is central to the
phospholipid biosynthesis pathways in cells. A pre-
vailing view is that only one CDP-DAG synthase
named Cds1 is present in both the endoplasmic re-
ticulum (ER) and mitochondrial inner membrane
(IM) and mediates generation of CDP-DAG from
phosphatidic acid (PA) and CTP. However, we
demonstrate here by using yeast Saccharomyces
cerevisiae as a model organism that Cds1 resides
in the ER but not in mitochondria, and that Tam41,
a highly conserved mitochondrial maintenance pro-
tein, directly catalyzes the formation of CDP-DAG
from PA in the mitochondrial IM. We also find that
inositol depletion by overexpressing an arrestin-
related protein Art5 partially restores the defects of
cell growth and CL synthesis in the absence of
Tam41. The present findings unveil the missing
step of the cardiolipin synthesis pathway in mito-
chondria as well as the flexibile regulation of phos-
pholipid biosynthesis to respond to compromised
CDP-DAG synthesis in mitochondria.
INTRODUCTION
Phospholipids, major components of cellular membranes, are
mainly generated via sequential modifications of PA by multiple
phospholipid-synthetic enzymes located in various cellular
compartments such as the ER, Golgi, and mitochondria (Henry
et al., 2012; Osman et al., 2011; van Meer et al., 2008). PA is
converted to an important intermediate CDP-DAG by CDP-
DAG synthase by using a nucleotide CTP (Shen et al., 1996).
Then phospholipid-synthetic pathways are branched intoCseveral different pathways, one of which leads to synthesis of
cardiolipin (CL), a mitochondria-specific phospholipid crucial
for optimal mitochondrial functions (Joshi et al., 2009; Claypool,
2009). The phospholipid synthetic pathway is well conserved
between yeast and mammals. For the synthesis of CL in yeast
Saccharomyces cerevisiae, CDP-DAG is first converted to
phophatidylglycerol phosphate (PGP) by Pgs1 PGP synthase
(Chang et al., 1998a), and then PGP is dephosphorylated to
form phophatidylglycerol (PG) by Gep4 PGP phosphatase
(Osman et al., 2010). PG and CDP-DAG are coupled to form
CL by Crd1 cardiolipin synthase (Tuller et al., 1998; Chang
et al., 1998b). For maturation of CL, Cld1 cardiolipin-specific
phospholipase and Taz1 acyltransferase remodel CL acyl chains
(Beranek et al., 2009; Gu et al., 2004). All these CL synthetic
enzymes are located in the mitochondrial IM or matrix while
ER-resident Cho1 PS synthase and Pis1 PI synthase convert
CDP-DAG to phosphatidylserine (PS) and phosphatidylinositol
(PI) by using serine and inositol, respectively (Henry et al.,
2012; Osman et al., 2011). In mammalian cells, PS is synthesized
from pre-existing PC or PE and serine through the base-
exchange reaction (Kuge and Nishijima, 1997; Vance and Tas-
seva, 2013). In S. cerevisiae, only one CDP-DAG synthase,
Cds1, was identified for formation of CDP-DAG (Shen et al.,
1996). Cds1 is conserved from bacteria to human, and its enzy-
matic activities are reportedly present in both the ER and mito-
chondrial IM (Kuchler et al., 1986; Kelley and Carman, 1987).
However, the precise cellular localization of Cds1 has not yet
been determined.
In this study, we carefully analyzed the cellular localization of
Cds1 and found that Cds1 is exclusively present in the ER, indi-
cating existence of another CDP-DAG synthase in mitochondria.
We further show that Tam41, a mitochondrial IM protein facing
the matrix (Tamura et al., 2006), functions as a CDP-DAG syn-
thase. Our findings solve a long-standing mystery of how cells
produce a key intermediate phospholipid, CDP-DAG, in distinct
organelles and provide insight into the CL synthetic pathway in
mitochondria.ell Metabolism 17, 709–718, May 7, 2013 ª2013 Elsevier Inc. 709
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Figure 1. Cds1 Is an ER-Resident Protein
(A–C) Crude and purifiedmitochondria and ER fractions were prepared from (A
and B) wild-type and Cds1FLAG or (C) Cds1FLAG-expressing (Cds1FLAG)
and Cds1FLAG-depleted (Cds1FLAGY) cells and analyzed by immunoblotting
with the indicated antibodies.
(D and E) ER and purified mitochondria fractions isolated from Cds1FLAG and
Cds1FLAGY cells were analyzed by immunoblotting with the indicated anti-
bodies.
(F and G) Phosphatidic acid (PA) and purified mitochondria or ER fractions
solubilized with Triton X-100 were incubated for the indicated time in the
presence of 32P-CTP. Phospholipids were then extracted and analyzed by
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Cds1 Functions in the ER
To examine the cellular location of Cds1, we purified the ER and
mitochondrial fractions from yeast cells expressing FLAG-
tagged Cds1 (Cds1FLAG) and performed immunoblotting of
Cds1 with the anti-FLAG antibody (Figure 1A). Cds1FLAG
was, like the ER protein marker Dpm1, mainly found in the
ER, but not in highly purified mitochondria, while the mitochon-
drial proteins Tim23 and Tom22 were enriched in the purified
mitochondrial fraction (Figure 1A). We also confirmed by using
anti-Cds1 antibodies that authentic Cds1 is enriched in the
ER (Figure 1B). These results indicate that Cds1 is an ER-resi-
dent protein, arguing against the prevailing view of the dual
localization of Cds1 in the ER and mitochondria. Rather, the re-
sults suggest the existence of a distinct CDP-DAG synthase in
mitochondria. To test this possibility, we utilized the yeast strain
expressing Cds1FLAG under the control of the TetO7 promoter
(Mnaimneh et al., 2004) and examined CDP-DAG synthase ac-
tivities of mitochondria purified from the cells with or without
Cds1FLAG depletion by addition of doxycycline. We confirmed
by using the anti-FLAG antibody that the expression level of
Cds1FLAG was significantly decreased in the ER fraction
upon Cds1FLAG depletion, while levels of mitochondrial pro-
teins such as Tim44, Tim23, and Pam16 were not affected (Fig-
ures 1C–1E). Then we monitored generation of CDP-DAG by
incubating PA with purified mitochondria or ER fraction, which
were solubilized with Triton X-100 in the presence of [a-32P]
CTP (Figures 1F and 1G). Mitochondria with and without
Cds1FLAG depletion showed similar CDP-DAG synthase activ-
ities, while production of CDP-DAG was dramatically decreased
in the Cds1FLAG-depleted ER fractions. This strongly suggests
that mitochondria possess a CDP-DAG synthase that is distinct
from Cds1.
Tam41 Is a CDP-DAG Synthase in Mitochondria
What is the identity of the mitochondrial protein responsible for
the observed CDP-DAG synthase activity? The putative mito-
chondrial CDP-DAG synthase is likely present in the IM or ma-
trix because it is reportedly protease insensitive even after
rupturing the mitochondrial outer membrane (OM; Kuchler
et al., 1986). Besides, loss of a mitochondrial CDP-DAG syn-
thase should lead to significant reductions in the CL level as
well as accumulations of PA, the precursor of CDP-DAG. On
the basis of these considerations, we reasoned that Tam41
could be a potential candidate. Tam41 is a peripheral IM protein
facing the matrix and was originally identified as a maintenance
protein for the IM translocator, the TIM23 complex (Tamura
et al., 2006; Gallas et al., 2006), which mediates translocation
of presequence-containing precursor proteins across or into
the IM. tam41D cells exhibit defects in cell growth at elevated
temperature and in mitochondrial protein import, likely due to
the destabilized TIM23 complex (Tamura et al., 2006; Gallas
et al., 2006). This destabilization of the TIM23 complex is asso-
ciated with loss of CL, which also destabilizes several IMTLC. Amount of CDP-DAGgenerated after 8min incubation inwild-type cells is
set to 100%. Values are mean ± SEM (n = 3).
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Figure 2. Tam41 Is a Mitochondrial CDP-DAG Synthase
(A) Purified Tam41-His6 and itsmutantswere analyzed by SDS-PAGE followed
by CBB staining.
(B) NBD-PA and purified Tam41 and Tam41mutants (Tam41-YGS and Tam41-
220A) were incubated for the indicated periods of time at 30C in the presence
or absence of CTP. Phospholipids were then extracted and analyzed by TLC.
Note that Tam41 appears to belong to the superfamily of nucleotidetransfer-
ase (NTase) fold proteins containing conserved active site residues, hG[GS],
[DE]h[DE]h, and h[DE]h (h indicates a hydrophobic amino acid) (Kuchta et al.,
2009). Tam41-YGSmutant has mutations in the hG[GS] motif, which may have
a role in holding substrates within the active site, while it is not clear if Asp220
functions in the active site, since intact [DE]h[DE]h and h[DE]h motifs are
missing in Tam41.
(C) CDP-DAG generated in vitro was further incubated with solubilized ER
fractions (ER lys.) in the presence or absence of serine. See also Figure S1.
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(Kutik et al., 2008).
We thus asked if Tam41 takes the role of the mitochondrial
CDP-DAG synthase. For this purpose, we overexpressed
C-terminally hexahistidine-tagged Tam41 under the GAL1 pro-
moter in yeast cells and purified it with the Ni-NTA agarose resin
followed by ion-exhange chromatography using SP-Sepharose
(Figure 2A, Tam41; see Figure S1A online). Then we measured
its CDP-DAG synthase activity by using a fluorescence-labeled
substrate, nitrobenzoxadiazole (NBD)-PA (Figure 2B). When we
incubated NBD-PA and purified Tam41, NBD-PA was efficiently
consumed, and an additional lipid product with smaller migration
similar to CDP-DAG on the TLC plate accumulated in a CTP-
dependent manner (Figure 2B, Tam41). As a negative control,
we used Tam41 mutants (Figure 2A, Tam41-220A and Tam41-
YGS) with the single and triple mutations, D220A and Y130A/
G131A/S132A, respectively, and confirmed that thesemutations
totally abolish the enzymatic activities (Figure 2B, Tam41-220A
and Tam41-YGS). This result is consistent with our previousCobservation that Tam41-220A and Tam41-YGS cannot comple-
ment the growth defects of the tam41D cells (Harada et al., 2010;
in this reference, the Art5 mutant Y130A/G131A/S132A was
mistakenly indicated as Y131A/G132A/S133A). To further
confirm the identity of the lipid product in Figure 2B as CDP-
DAG, we tested whether it could be converted to a subsequent
phospholipid such as PS in the lipid synthetic pathway. We first
incubated 10 mMNBD-PA with purified Tam41 in the presence of
the excess amount of CTP (1 mM) for 30 min until NBD-PA was
completely consumed, so that the lipid product was exclusively
present (Figure 2C, 1st, Tam41+). Then the lipid procuct was
incubated with the Triton X-100-solubilized ER fraction contain-
ing Cho1 PS synthase in the presence of serine (Figure 2C, 2nd,
ER lysate, Ser+), which resulted in generation of a phospholipid
comigrating with NBD-PS. This indicates that the accumulating
lipid product with a slower migration was indeed CDP-DAG (Fig-
ure 2C). Taken together, we conclude that Tam41 directly cata-
lyzes the conversion of PA to CDP-DAG in the presence of CTP.
Yeast cells thus have two distinct CDP-DAG synthases, Cds1
and Tam41, residing in the ER and mitochondrial IM, respec-
tively, for phospholipid biosynthesis.
Identificaiton of Tam41 as amitochondrial CDP-DAG synthase
means that four CL synthetic enzymes, Tam41, Pgs1, Gep4, and
Crd1, are in operation in yeast mitochondria. Interestingly,
although yeast mutants lacking one of these enzymes are not
able to produce CL in common, they are phenotypically different.
tam41D and pgs1D cells showed severe growth defects on
fermentable (Figure S1B, YPD) or nonfermentable (Figure S1C,
YPGE) media at high temperature as compared with gep4D
and crd1D cells, and the growth defects of gep4D cells were
stronger than those of crd1D cells. As reported previously (Kutik
et al., 2008; Gebert et al., 2009; Osman et al., 2010), blue native
PAGE analyses showed that those CL synthesis mutants have a
slightly smaller TOM40 complex in the OM and smaller TIM23
and TIM22 complexes in the IM (Figure S1D). The respiratory-
chain supercomplex consisting of complexes III and IV and the
TOM40 complex was partly destabilized in tam41D and pgs1D
mitochondria, and a part of complex V fell apart in pgs1D mito-
chondria (Figure S1D). In tam41D and pgs1D mitochondria, but
not in gep4D or crd1D mitochondria, the steady-state levels of
cytochrome c1 (Cyt c1) of complex III and cytochrome oxidase
subunit IV (Cox4) of complex IV were decreased (Figures S1D
and S1E). These phenotypic differences are probably caused
by accumulation of different intermediate phospholipids such
as PA, CDP-DAG, PGP, or PG in tam41D, pgs1D, gep4D, or
crd1D cells, respectively, in mitochondria.
Enzymological Properties of Tam41
Next, we characterized the enzymological properties of purified
Tam41 CDP-DAG synthase. First, we tested the requirement of
divalent metal ions. The Cds1 CDP-DAG synthase activity re-
quires Mg2+ and is inhibited by EDTA (Kelley and Carman,
1987; Nigou and Besra, 2002; Figure 3A). Similarly, highly puri-
fied mitochondria containing Tam41 CDP-DAG synthase were
not able to produce CDP-DAG in the presence of EDTA (Fig-
ure 3A). Dependence of the Tam41 CDP-DAG activity on
different divalent metal ions was, however, not exactly the
same as that of the Mycobacterium smegmatis Cds1 CDP-
DAG synthase activity (Nigou and Besra, 2002) (Figure 3B). Forell Metabolism 17, 709–718, May 7, 2013 ª2013 Elsevier Inc. 711
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Figure 3. Enzymological Analyses of Tam41
(A) CDP-DAG synthase activities of highly purified ER and mitochondria frac-
tions were measured in the presence of 10 mM EDTA.
(B) Purified Tam41 and NBD-PA were incubated in the presence of 3 mM
divalent metal ions for 5 min. The CDP-DAG synthase activity detected in the
presence of Mg2+ was set to 100%. Values are mean ± SEM (n = 3).
(C) pH profile of Tam41 CDP-DAG synthase. Tam41 CDP-DAG activity was
determined at varying pH. The buffers used are 50 mM PIPES-NaOH (pH 6.0)
and6.5, 50mMTris-HCl (pH7.0, 7.5, 8.0, 8.5, and8.9), and50mMCAPS-NaOH
(pH 10 and 11). The CDP-DAG activity obtained at pH 8.0 was set to 100%.
(D and E) Kinetic analyses of Tam41 CDP-DAG synthase on the concentrations
of NBD-PA andCTP. NBD-PA and purified Tam41were incubated for 10min at
30C. CTP (2 mM) or 250 mMNBD-PA was used for experiments in (D) and (E),
respectively. Curve fitting was performed with Prism 6.0 (GraphPad software).
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DAG synthase activity in the presence of Co2+ (80%of the case
for Mg2+) and Cu2+ (30% of the case for Mg2+). Next, we fol-
lowed the pH dependence of the Tam41 CDP-DAG synthase ac-
tivity in the range of pH 6–11 and found that the enzymatic activ-
ity is maximal at around pH 7–9 (Figure 3C).
By measuring the Tam41 CDP-DAG synthase activities at
different concentrations of NBD-PA and CTP, we confirmed
that the CDP-DAG synthase activities follow normal saturation
kinetics and analyzed the data to obtain enzymatic kinetic pa-
rameters, Km for NBD-PA and CTP and Vmax (Figures 3D and
3E). The obtained Km value for NBD-PA was 0.067 ± 0.01 mM,
which is smaller than the Km values for PA for Cds1 from yeast
(0.50 mM), E. coli (0.28 mM), Plasmodium falciparum
(0.90 mM), and M. smegmatis (0.61 mM) (Kelley and Carman,
1987; Martin et al., 2000; Nigou and Besra, 2002; Sparrow and
Raetz, 1985). The small Km value for NBD-PA for Tam41 may
well reflect the higher affinity of Tam41 for PA than Cds1 CDP-
DAG synthases, although it may be perhaps due to the nature
of the unnatural phospholipid, NBD-PA, which contains a rela-
tively short acyl chain in addition to the normal length of the
acyl chain, as compared with PA. The Km value for CTP was
0.76 ± 0.14 mM, which is similar to those for Cds1 from yeast
(1.0 mM) and E. coli (0.58 mM) (Kelley and Carman, 1987; Spar-
row and Raetz, 1985). The Vmax value was 68 ± 3.0 nmol/min/mg,712 Cell Metabolism 17, 709–718, May 7, 2013 ª2013 Elsevier Inc.which is smaller than that for yeast Cds1 (4,700 nmol/min/mg)
(Kelley and Carman, 1987).
Decreased Inositol Level Restores the Growth Defects
of tam41D Cells
Recently, we identified Art5, a member of the arrestin-related
trafficking adaptor (ART) protein family (Lin et al., 2008), as a
multicopy suppressor for the temperature-sensitive tam41-ts
aswell as the tam41Dmutants (Harada et al., 2010). Overexpres-
sion of Art5 restored the temperature-sensitive growth defects of
tam41D cells completely on fermentable media (Figure 4A, SCD)
but only partly on nonfermentable media, which renders the cell
growth dependent on mitochondrial respiration (Figure 4A,
SCGly) (Harada et al., 2010).
Art5mediates regulated degradation of the inositol transporter
Itr1 in response to exogenous inositol (Lin et al., 2008; Nikko and
Pelham, 2009). This raises a possibility that overexpression of
Art5 perturbs phospholipid biosynthetic pathways through
an altered cellular level of inositol. Indeed, PI levels decreased
when Art5 was overexpressed (Figure 5A). We thus tested the
effects of deletion of the ITR1 gene on the growth of tam41D
and several mutant strains with decreased CL levels,
crd1D (Chang et al., 1998b), gep4D (Osman et al., 2010), and
ups1D (Tamura et al., 2009; Osman et al., 2009) and with a
decreased PE level, psd1D (Clancey et al., 1993) (Figure 4B).
Ups1was recently found tomediate intramitochondrial transport
of PA (Connerth et al., 2012). The growth defects of tam41D at
elevated temperature were suppressed by the simultaneous
deletion of the ITR1 gene (Figure 4B). In contrast, the weak
growth defects of crd1D, gep4D, psd1D, or ups1D cells were
not suppressed by the ITR1 deletion (Figure 4B). We then
depleted inositol from the culture medium instead of deletion
of the ITR1 gene. Depletion of inositol restored the growth
defects of tam41D cells, but not of crd1D, psd1D, gep4D, or
ups1D cells (Figure 4C). Steady-state levels of inositol trans-
porters Itr1 and Itr2 decrease in tam41D cells likely in order to
adopt the circumstances of compromised CL synthesis (Fig-
ure 4D). Since the Art5 overexpression, depletion of inositol,
and deletion of the ITR1 inositol transporter gene suppress the
growth defects of tam41D cells specifically and in similar man-
ners, overexpression of Art5 likely compensates for the lack of
Tam41 through decrease in the cellular level of inositol.
Overexpression of Art5 Alters Phospholipid Profiles in
tam41D Cells
Interestingly, overexpression of Cds1, the ER CDP-DAG syn-
thase, rescued temperature-sensitive growth defects of
tam41D cells lacking the mitochondrial CDP-DAG synthase on
fermentable media (Figure 4A, SCD), although it did not on non-
fermentable media (Figure 4A, SCGly). Besides, overexpression
of both Cds1 and Art5 synergetically rendered tam41D cells
completely capable of growing on nonfermentable as well as
fermentable media at 37C (Figure 4A). This suggests the possi-
bility of the uncharacterized delivery route of CDP-DAG from the
ER to mitochondria, which could become prominent upon Cds1
overexpression and then result in restoration of the CL level in
mitochondria. However, the effects of Cds1 or Art5 overexpres-
sion are complicated, since the CL level was not restored in
tam41D cells by Cds1 overexpression alone (Figure 5A). Instead,
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Figure 4. Decreased Inositol Uptake Re-
stores the Growth Defects of tam41D Cells
(A) Serial dilutions of tam41D cells with amulticopy
plasmid harboring the TAM41, PIS1, CDS1, or
ART5 genes or empty vector were spotted onto
glucose- or glycerol-containing media and culti-
vated for 2 or 4 days, respectively.
(B and C) Serial dilutions of the indicated yeast
strains were spotted on SCD plates at 23C or
37C (B) or on synthetic minimal plates with or
without inositol at 23C or 37C (C).
(D) Whole-cell extracts prepared from wild-type
and tam41D cells expressing C-terminally HA-
tagged Itr1 or Itr2 were analyzed by immunoblot-
ting with the antibodies against HA tag and Tim23.
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and CDP-DAG in tam41D cells (Figure 5A), despite the fact
that overexpression of Cds1 alone increased production of
CDP-DAG in the ER more significantly than did Art5 overexpres-
sion in vitro (Figure 5B). These results suggest that overproduc-
tion of CDP-DAG alone in the ER is not sufficient to accumulate
detectable amounts of CDP-DAG and CL, or in other words that
the transport of CDP-DAG from the ER to mitochondria is there-
fore, if at all, inefficient.
Importantly, overexpression of both Cds1 and Art5 rescued
growth defects of pgs1Dtam41D cells, which are presumably
unable to produce CL (Figure 5C). This suggests that restoration
of the CL level may not be the sole mechanism for the retrieval
of the defective growth of tam41D cells by Art5 overexpression
or inositol depletion. In relation to this, we note that when Art5
was overexpressed, the levels of phospholipids other than CL
were also perturbed; CDP-DAG, PA, and PE levels increased
while the PI level decreased (Figure 5A). Since CL is an acidic
phospholipid that favors local nonbilayer structures, acidic
phospholipids CDP-DAG and PA and non-bilayer-forming lipid
PE could functionally substitute the roles of CL in part (Gohil
et al., 2005; Joshi et al., 2012; Rand and Sengupta, 1972; van
den Brink-van der Laan et al., 2004). Therefore not only CL
restoration but also overall changes in the phospholipid profile
including the levels of CDP-DAG, PA, and PE may give positive
effects on cell growth in the absence of Tam41.
DISCUSSION
In this study, we found that two CDP-DAG synthases, Cds1 and
Tam41, function in distinct organelles, the ER and mitochondria,
respectively, in yeast (Figure 6). Eukaryotic cells require twoCell Metabolism 17, 709CDP-DAG synthases in the ER and mito-
chondria for efficient phospholipid syn-
thesis due to inefficient CDP-DAG trans-
port between the ER and mitochondria.
Both Tam41 and Cds1 are highly
conserved proteins, yet their origins
seem to be different. Our sequence anal-
ysis and a previous study (Kuchta et al.,
2009) suggest that the N-terminal portion
of Tam41 may possess the nucleotide
transferase (NTase) fold, which is consis-tent with the CDP-DAG synthase function of Tam41, although
the NTase activity of Tam41 and its family members had not
been predicted. In contrast, Cds1 exhibits the CDP-DAG syn-
thase, i.e., NTase activity, yet it does not contain the NTase
fold. While orthologs of Tam41 are present exclusively in eukary-
otes (Figure 7A), potential homologs of Tam41 are well
conserved in proteobacteria including a-proteobacteria, which
are close to the presumable endosymbiotic origin of mitochon-
dria (Figure 7C) (Gray et al., 1999). On the other hand, orthologs
of Cds1 can bewidely found in prokaryotes aswell as eukaryotes
(Figure 7B). Therefore Cds1 was likely derived from the ancient
eukaryotes that took upmitochondrial ancestors, and eukaryotic
cells have conserved two distinct CDP-DAG synthases, Tam41
andCds1, after establishment ofmitochondria. A possible evolu-
tionary constraint behind this could be that while PA is trans-
ported from the ERmembrane to the mitochondrial IM efficiently
(Connerth et al., 2012), transport of CDP-DAG between the ER
membrane and mitochondrial IM, if any, may be inefficient, as
discussed later. Cds1 and Tam41 have therefore developed their
own commitment to lipid biosynthetic pathways operating in two
evolutionary distinct organelles, the ER andmitochondria, during
evolution of eukaryotic cells.
The present study indicates that Art5 overexpression rescues
the growth defects of tam41D cells through decrease in inositol
uptake. Previous studies have shown that the Ino2-Ino4 hetero-
dimer binds to inositol-sensitive upstream activating element
(UASINO) and activates transcription of a number of phospholipid
synthetic enzymes including Cds1, Cho1, Psd1, and Cho2/Opi3
for the CDP-DAG, PS, PE, and PC synthases, respectively, upon
depletion of inositol (Henry et al., 2012; Greenberg and Lopes,
1996). Besides, it was also reported that the Pgs1 enzymatic ac-
tivity can be upregulated through reduced phosphorylation of–718, May 7, 2013 ª2013 Elsevier Inc. 713
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Figure 5. Phospholipid Profiles of tam41D Cells upon Overexpression of Art5 or Cds1
(A) WT and tam41D cells with a multicopy plasmid harboring the indicated gene or empty vector were cultivated in YPD containing 32P at 30C. Total phos-
pholipids were extracted fromwhole cells and separated on TLC for 2 hr (left) or 4 hr (right). A part of TLC plate showing PDME and CL is shownwith high contrast
(left below). Amounts of each lipid relative to total phospholipids (above) and to those in WT cells (except for CDP-DAG) (below) were determined. In the latter
representation, the amount of CDP-DAG relative to that in the ‘‘tam41D+ART5’’ strain (CDP-DAG) was shown. Values are mean ± SEM (n = 3).
(B) CDP-DAG synthetic activities in ER fractions. Triton X-100-solubilized ER fractions prepared from wild-type cells with or without overexpression of Art5 or
Cds1were incubated with 100 mMNBD-PA in the presence of 2mMCTP for the indicated times at 30C. Amounts of CDP-DAG generated after 30min incubation
in wild-type ER fraction are set to 100%.
(C) Overexpression of Cds1 and Art5 rescues growth defects of tam41Dpgs1D cells. Serial dilutions of tam41D and tam41Dpgs1D cells with multicopy plasmids
expressing both Cds1 and Art5 or with empty vectors were spotted onto YPD and cultivated for 3 days. See also Figure S2.
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A CDP-DAG Synthase in MitochondriaPgs1 in response to inositol depletion (He and Greenberg, 2004).
Therefore, inositol depletion could likely compensate for the loss
of Tam41 by transcriptional control of the proteins involved in
phospholipid biosynthesis and/or transport.
To examinewhether CDP-DAG has an ability to be transported
into mitochondria from the other organelles like the ER by
crossing the aqueous environment, we conducted in vitro
CDP-DAG transport assay using mitochondria isolated from
wild-type and mutant cells lacking one of the four CL synthetic
enzymes, Tam41, Pgs1, Gep4, and Crd1, and liposomes con-
taining NBD-CDP-DAG, as reported previously (Tamura et al.,
2012). Interestingly, NBD-CDP-DAG was taken up by mitochon-714 Cell Metabolism 17, 709–718, May 7, 2013 ª2013 Elsevier Inc.dria and was converted to other NBD-containing substances
(likely lipids and other acyl-containing species) in wild-type,
tam41D, gep4D, and crd1D mitochondria (Figure S2A). In
contrast, NBD-CDP-DAG associated with mitochondria was
hardly consumed in the absence of Pgs1, which converts
CDP-DAG to PGP. The Pgs1-dependent conversion of CDP-
DAG indicates that externally added CDP-DAG is imported into
mitochondria, crossing the OM and IM to reach the matrix side
where Pgs1 is located. When NBD-PA instead of NBD-CDP-
DAG was added in the in vitro lipid transport assay, NBD-PA
was also converted to other NBD-containing substances
including CDP-DAG, which was not consumed efficiently in
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Figure 6. Phospholipid Biosynthesis Lead-
ing to CL, PI, and PS in Mitochondria and
the ER
Broken lines indicate putative transport routes.
OM, mitochondrial outer membrane; IM, mito-
chondrial inner membrane; PM, plasma mem-
brane.
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A CDP-DAG Synthase in Mitochondriapgs1Dmitochondria (Figure S2B). Note that the Gep4-catalyzing
reaction may not work properly in this assay system, since
possible NBD-PGP species accumulate at similar levels be-
tween gep4D and crd1D mutant strains. Although these results
may suggest the potential ability of CDP-DAG to be transported
from the ER to mitochondria across the aqueous environment,
we should be aware that conjugation of the NBD moiety to the
short acyl chain of CDP-DAG may change the property of
CDP-DAG, thereby affecting the efficiency in uptake of NBD-
CDP-DAG by mitochondria. Indeed, our results on cellular phos-
pholipid profiles suggest that suchCDP-DAG transport pathway,
if any, should be very inefficient in terms of CL synthesis
(Figure 5A).
Possible inefficient transport of CDP-DAG from the ER tomito-
chondriamay further require facilitated transport systems in vivo.
Perhaps Art5 overexpression or inositol depletion, but not the
Cds1 overexpression alone, may accelerate the facilitated trans-
port of CDP-DAG from the ER to mitochondria. Since tam41D
cells show synthetic growth defects with deletion of an ER-mito-
chondria encounter structure (ERMES) subunit, Mdm12 (Fig-
ure S2C), CDP-DAG transport between the ER andmitochondria
may involve the ERMES complex, which is proposed to facilitate
phospholipid exchange between the ER and mitochondria by
tethering the two organelles (Kornmann et al., 2009). Clearly,
more precise analyses of the mitochondrial lipid contents should
be required to characterize the possible inefficient CDP-DAG
transport from the ER to mitochondria.
In conclusion, the present study has revealed that a CDP-DAG
synthase Tam41 operates in the CL biosynthesis pathway in
mitochondria, and thus it fills the last missing link for the CL syn-
thetic pathway in mitochondria. Although depletion of Tam41
blocks the CL synthetic pathway, cells have a mechanism to
circumvent the lack of Tam41 by likely modulating the cellular
level of inositol, which may affect the CDP-DAG transport from
the ER tomitochondria and/or phospholipid profiles inmitochon-
dria. It will be of great interest to explore in future studies how the
change in the cellular inositol level leads to optimization of the CL
and other phospholipid levels in mitochondria to maintain mito-
chondrial functional homeostasis.EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids
Yeast strains used in this work are listed in Table S1. Gene disruption was per-
formed by genomic gene replacement with the CgHIS3 or CgTRP1 genesCell Metabolism 17, 709amplified from pCgHIS3 or pCgTRP1 (Kitada
et al., 1995). The gene for Cds1FLAG was con-
structed by homologous recombination of FY833
or YSC1180-7428809 (Open Biosystems) with
the FLAG-KanMX6 or FLAG-HIS3 gene cassettesamplified from pFA6a-FLAG-kanMX6 or pFA6a-FLAG-HIS3 (Tamura et al.,
2010).
pYES2-CT-Tam41, an URA3-2m plasmid that expresses C-terminally hexa-
histidine-tagged Tam41 under the GAL1 promoter, was constructed as fol-
lows. The TAM41 gene was amplified from pRS314-Tam41 (Tamura et al.,
2006) using primers YES2TAM41F (AGGGAATATTAAGCTATGTTAC
GAGTTTCTGAAAATGGT) and YES2TAM41R (GCCCTCTAGACTCGAA
GCTTCTCCTCATCGATTTTAGTTT). The PCR product was ligated into Hin-
dIII/XhoI-digested pYES2/CT (Invitrogen) by using In-Fusion HD Cloning Kit
(Clontech).
Antibodies
For detection of FLAG epitope, anti-FLAGM2monoclonal antibody (Sigma) or
anti-DYKDDDDK tag, monoclonal antibody (1E6) (Wako Pure Chemical Indus-
tries, Ltd.), was used. HA epitope was detected using anti-HA tag mAb
(TANA2) (Medical & Biological Laboratories Co., Ltd.). Anti-Dpm1 yeast mono-
clonal antibody (5C5A7) was purchased from Invitrogen. Purified Cds1 anti-
bodies were a gift from Nikolaus Pfanner (University of Freiburg). Preparation
of anti-Tam41 antibodies was described previously (Tamura et al., 2006).
Growth Conditions
Cells were grown in YPD (1% yeast extract, 2% polypeptone, and 2%
glucose), YPLac (1% yeast extract, 2% polypeptone, and 2% lactate),
YPGE (1% yeast extract, 2% polypeptone, 3% glycerol, and 2% ethanol),
YPGalSuc (1% yeast extract, 2% polypeptone, 2% galactose, and 2% su-
crose), SD (0.67% yeast nitrogen base without amino acids and 2% glucose),
SCD (0.67% yeast nitrogen base without amino acids, 0.5% casamino acids,
and 2% glucose), or SCGly (0.67% yeast nitrogen base without amino acids,
0.5% casamino acids, and 2% glycerol) media. SD, SCD, and SCGly media
were supplemented appropriately with 20 mg/ml each of adenine sulfate,
L-tryptophan, L-histidine, methionine, and uracil and 30 mg/ml each of
L-leucine and L-lysine. Synthetic minimal plates with or without inositol were
prepared as described (Sherman, 1991).
Purification of Tam41 from Yeast Cells
Yeast cells with pYES2-CT-Tam41 were cultivated in YPGalSuc, and crude
mitochondrial fractions were prepared. The mitochondria were solubilized
in DDM buffer (1% n-dodecyl b-D-maltoside, 20 mM Tris-HCl [pH 7.5],
300 mM KCl, 2 mM MgCl2, 10% glycerol, 10 mM imidazole) and subjected
to Ni-NTA affinity purification. After washing the Ni-NTA resin with wash
buffer (1% Triton X-100, 20 mM Tris-HCl [pH 7.5], 2 mM MgCl2, 2 mM b-mer-
captoethanol, and 30 mM imidazole) with 300 mM and 50 mM KCl, respec-
tively, proteins were eluted with elution buffer (0.2% Triton X-100, 20 mM
Tris-HCl [pH 7.5], 80 mM KCl, 2 mM MgCl2, 10% glycerol, and 250 mM imid-
azole). Eluted proteins were dialyzed against dialysis buffer (0.2% Triton
X-100, 20 mM Tris-HCl [pH 7.5], 10% glycerol, and 2 mM b-mercaptoethanol)
and subjected to ion-exchange chromatography with SP-Sepharose to
obtain Tam41. Tam41 was eluted with 100 mM NaCl (0.2% Triton X-100,
20 mM Tris-HCl [pH 7.5], 10% glycerol, 2 mM b-mercaptoethanol, and
100 mM NaCl).–718, May 7, 2013 ª2013 Elsevier Inc. 715
Figure 7. Taxonomic Distribution of Tam41
and Cds1 Homologs
(A and B) Two sunburst charts adopted from Pfam
show the distribution of PF09139 including Tam41
(A) and PF01148 including Cds1 (B) across spe-
cies. Segments shown in purple represent the
proteins in eukaryotes, and green segments
represent bacterial proteins. Detailed explana-
tions of color assignments are given in a rectangle.
Names of three bacterial species that have ho-
mologous proteins of PF09139 are shown.
(C) Evolutionary relationships of yeast Tam41 and
its homologs in bacteria. The tree was colored to
depict subdivisions of proteobacteria. Confidence
values from 1,000 resamplings are shown.
Cell Metabolism
A CDP-DAG Synthase in MitochondriaPhospholipid Analysis
To prepare total phospholipids from whole cells, overnight cultures of yeast
cells were diluted to OD600 = 0.01 in 1 ml of YPD containing 5 mCi/ml
32Pi
and cultivated for 20 hr at 30C. Phospholipids were extracted from cells
and subjected to TLC analyses using chloroform/ethanol/water/triethylamine
(30:35:7:35) as a solvent (Vaden et al., 2005). Labeled phospholipids were
analyzed by radioimaging with a Typhoon 9200 (GE Healthcare) or PharosFX
Plus Molecular Imager (Bio-Rad).Cell Fractionation
Yeast cells were grown in YPGE and treated with Zymolyase 20T (Seikagaku
Corp.). The resulting spheroplasts were homogenized and centrifuged at
1,500 3 g, and the supernatant was centrifuged at 12,000 3 g to obtain
crude mitochondria. The postmitochondrial supernatant was centrifuged at
30,000 3 g to get rid of residual mitochondria and further centrifuged at
40,000 3 g to obtain the microsome (ER) fraction. The crude mitochondria
fraction was subjected to a step sucrose gradient or an Optiprep density
gradient (Axis-Shield) to obtain highly purified mitochondria as described
previously (Meisinger et al., 2000) or according to the manufacturer’s
instructions.716 Cell Metabolism 17, 709–718, May 7, 2013 ª2013 Elsevier Inc.Assays for CDP-DAG Synthase Activity
Unless otherwise stated, to measure the CDP-
DAG synthase activity, 10 mMNBD-PA (Avanti Po-
lar Lipids, catalog number 810174) was incubated
with either 2 mg/ml purified mitochondria, 1 mg/ml
ER, or 250 nM purified Tam41 in 50 ml of assay
buffer (20 mM Tris-HCl [pH 7.5], 80 mM KCl,
2 mM MgCl2, 0.2% Triton X-100, 10% glycerol)
with either 740 kBq (6.7 pmol)/ml 32P-CTP or
1 mM CTP for the indicated time periods at
30C. After the incubation, 750 ml of 2:1 chloro-
form/methanol was added to the samples and vor-
texed for 15 min to extract lipids. Water (100 ml)
was then added to the sample and vortexed for
5min. The organic phase was separated by centri-
fugation at 4003 g for 5 min, dried in a speedvac,
and then resuspended in 80 ml of chloroform.
Samples (20 ml) were loaded and analyzed by
TLC using chloroform/ethanol/water/triethylamine
(30:35:7:35) or chloroform/methanol/acetic acid/
water (50:28:4:8) as a solvent (Nigou and Besra,
2002; Vaden et al., 2005). Phospholipids were
analyzed by radioimaging or fluorescence imaging
with a Typhoon 9200 (GE Healthcare) or PharosFX
Plus Molecular Imager (Bio-Rad).
Phylogenetic Analysis
Forty bacterial homologous sequences of Tam41
were detected by Jackhmmer (Finn et al., 2011)
with the UniProt database, by using three bacterial homologs (Figure 7A) in
Pfam 26.0 (Finn et al., 2010) as query sequences. Amultiple alignment of those
sequences and yeast Tam41 was calculated by MAFFT version 6 (Katoh and
Toh, 2008) with the L-INS-i strategy and homologs with the BLAST E values
<1010 from SwissProt. A phylogenetic tree of them was constructed using
the neighbor-joining method under the JTT model with ungapped sites of
the multiple alignment (http://mafft.cbrc.jp/alignment/software/).
Statistical Analysis
The error bars for experimental results indicate SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at http://dx.doi.org/10.1016/j.cmet.2013.03.018.
ACKNOWLEDGMENTS
We thank Dr. Nikolaus Pfanner for antibodies against Cds1. We are grateful
to the members of the Endo lab for valuable discussions. K.I. is a research
Cell Metabolism
A CDP-DAG Synthase in Mitochondriafellow of the Japan Society for the Promotion of Science (JSPS). We acknowl-
edge support of this work by Grants-in-Aid for Scientific Research from
the Ministry of Education, Culture, Sports, Science, and Technology of Japan
(MEXT) and the grant for CREST from Japan Science and Technology Agency
(JST) to T.E.; a grant of the Platform for DrugDiscovery, Informatics, and Struc-
tural Life Science from the MEXT to K.T.; and a NIH (GM089853) to H.S.
Received: October 24, 2012
Revised: January 23, 2013
Accepted: March 28, 2013
Published: April 25, 2013
REFERENCES
Beranek, A., Rechberger, G., Knauer, H., Wolinski, H., Kohlwein, S.D., and
Leber, R. (2009). Identification of a cardiolipin-specific phospholipase en-
coded by the gene CLD1 (YGR110W) in yeast. J. Biol. Chem. 284, 11572–
11578.
Chang, S.C., Heacock, P.N., Clancey, C.J., and Dowhan, W. (1998a). The
PEL1 gene (renamed PGS1) encodes the phosphatidylglycero-phosphate
synthase of Saccharomyces cerevisiae. J. Biol. Chem. 273, 9829–9836.
Chang, S.C., Heacock, P.N., Mileykovskaya, E., Voelker, D.R., and Dowhan,
W. (1998b). Isolation and characterization of the gene (CLS1) encoding cardi-
olipin synthase in Saccharomyces cerevisiae. J. Biol. Chem. 273, 14933–
14941.
Clancey, C.J., Chang, S.C., and Dowhan, W. (1993). Cloning of a gene (PSD1)
encoding phosphatidylserine decarboxylase from Saccharomyces cerevisiae
by complementation of an Escherichia coli mutant. J. Biol. Chem. 268,
24580–24590.
Claypool, S.M. (2009). Cardiolipin, a critical determinant of mitochondrial car-
rier protein assembly and function. Biochim. Biophys. Acta 1788, 2059–2068.
Connerth, M., Tatsuta, T., Haag, M., Klecker, T., Westermann, B., and Langer,
T. (2012). Intramitochondrial transport of phosphatidic acid in yeast by a lipid
transfer protein. Science 337, 815–818.
Finn, R.D., Mistry, J., Tate, J., Coggill, P., Heger, A., Pollington, J.E., Gavin,
O.L., Gunasekaran, P., Ceric, G., Forslund, K., et al. (2010). The Pfam protein
families database. Nucleic Acids Res. 38(Database issue), D211–D222.
Finn, R.D., Clements, J., and Eddy, S.R. (2011). HMMER web server: interac-
tive sequence similarity searching. Nucleic Acids Res. 39(Web Server issue),
W29–W37.
Gallas, M.R., Dienhart, M.K., Stuart, R.A., and Long, R.M. (2006).
Characterization of Mmp37p, a Saccharomyces cerevisiae mitochondrial ma-
trix protein with a role in mitochondrial protein import. Mol. Biol. Cell 17, 4051–
4062.
Gebert, N., Joshi, A.S., Kutik, S., Becker, T., McKenzie, M., Guan, X.L., Mooga,
V.P., Stroud, D.A., Kulkarni, G., Wenk, M.R., et al. (2009). Mitochondrial cardi-
olipin involved in outer-membrane protein biogenesis: implications for Barth
syndrome. Curr. Biol. 19, 2133–2139.
Gohil, V.M., Thompson, M.N., and Greenberg, M.L. (2005). Synthetic lethal
interaction of the mitochondrial phosphatidylethanolamine and cardiolipin
biosynthetic pathways in Saccharomyces cerevisiae. J. Biol. Chem. 280,
35410–35416.
Gray, M.W., Burger, G., and Lang, B.F. (1999). Mitochondrial evolution.
Science 283, 1476–1481.
Greenberg, M.L., and Lopes, J.M. (1996). Genetic regulation of phospholipid
biosynthesis in Saccharomyces cerevisiae. Microbiol. Rev. 60, 1–20.
Gu, Z., Valianpour, F., Chen, S., Vaz, F.M., Hakkaart, G.A., Wanders, R.J., and
Greenberg, M.L. (2004). Aberrant cardiolipin metabolism in the yeast taz1
mutant: a model for Barth syndrome. Mol. Microbiol. 51, 149–158.
Harada, Y., Tamura, Y., and Endo, T. (2010). Identification of yeast Art5 as a
multicopy suppressor for the mitochondrial translocator maintenance protein
Tam41. Biochem. Biophys. Res. Commun. 392, 228–233.
He, Q., and Greenberg, M.L. (2004). Post-translational regulation of phospha-
tidylglycerolphosphate synthase in response to inositol. Mol. Microbiol. 53,
1243–1249.CHenry, S.A., Kohlwein, S.D., and Carman, G.M. (2012). Metabolism and regu-
lation of glycerolipids in the yeast Saccharomyces cerevisiae. Genetics 190,
317–349.
Joshi, A.S., Zhou, J., Gohil, V.M., Chen, S., and Greenberg, M.L. (2009).
Cellular functions of cardiolipin in yeast. Biochim. Biophys. Acta 1793,
212–218.
Joshi, A.S., Thompson, M.N., Fei, N., Hu¨ttemann, M., and Greenberg, M.L.
(2012). Cardiolipin andmitochondrial phosphatidylethanolamine have overlap-
ping functions in mitochondrial fusion in Saccharomyces cerevisiae. J. Biol.
Chem. 287, 17589–17597.
Katoh, K., and Toh, H. (2008). Recent developments in the MAFFT multiple
sequence alignment program. Brief. Bioinform. 9, 286–298.
Kelley, M.J., and Carman, G.M. (1987). Purification and characterization of
CDP-diacylglycerol synthase from Saccharomyces cerevisiae. J. Biol. Chem.
262, 14563–14570.
Kitada, K., Yamaguchi, E., and Arisawa, M. (1995). Cloning of the Candida
glabrata TRP1 and HIS3 genes, and construction of their disruptant strains
by sequential integrative transformation. Gene 165, 203–206.
Kornmann, B., Currie, E., Collins, S.R., Schuldiner, M., Nunnari, J., Weissman,
J.S., andWalter, P. (2009). An ER-mitochondria tethering complex revealed by
a synthetic biology screen. Science 325, 477–481.
Kuchler, K., Daum, G., and Paltauf, F. (1986). Subcellular and submitochon-
drial localization of phospholipid-synthesizing enzymes in Saccharomyces
cerevisiae. J. Bacteriol. 165, 901–910.
Kuchta, K., Knizewski, L., Wyrwicz, L.S., Rychlewski, L., and Ginalski, K.
(2009). Comprehensive classification of nucleotidyltransferase fold proteins:
identification of novel families and their representatives in human. Nucleic
Acids Res. 37, 7701–7714.
Kuge, O., and Nishijima, M. (1997). Phosphatidylserine synthase I and II of
mammalian cells. Biochim. Biophys. Acta 1348, 151–156.
Kutik, S., Rissler, M., Guan, X.L., Guiard, B., Shui, G., Gebert, N., Heacock,
P.N., Rehling, P., Dowhan, W., Wenk, M.R., et al. (2008). The translocator
maintenance protein Tam41 is required for mitochondrial cardiolipin biosyn-
thesis. J. Cell Biol. 183, 1213–1221.
Lin, C.H., MacGurn, J.A., Chu, T., Stefan, C.J., and Emr, S.D. (2008). Arrestin-
related ubiquitin-ligase adaptors regulate endocytosis and protein turnover at
the cell surface. Cell 135, 714–725.
Martin, D., Gannoun-Zaki, L., Bonnefoy, S., Eldin, P., Wengelnik, K., and Vial,
H. (2000). Characterization of Plasmodium falciparumCDP-diacylglycerol syn-
thase, a proteolytically cleaved enzyme.Mol. Biochem. Parasitol. 110, 93–105.
Meisinger, C., Sommer, T., and Pfanner, N. (2000). Purification of
Saccharomcyes cerevisiae mitochondria devoid of microsomal and cytosolic
contaminations. Anal. Biochem. 287, 339–342.
Mnaimneh, S., Davierwala, A.P., Haynes, J., Moffat, J., Peng, W.T., Zhang,W.,
Yang, X., Pootoolal, J., Chua, G., Lopez, A., et al. (2004). Exploration of essen-
tial gene functions via titratable promoter alleles. Cell 118, 31–44.
Nigou, J., and Besra, G.S. (2002). Cytidine diphosphate-diacylglycerol synthe-
sis in Mycobacterium smegmatis. Biochem. J. 367, 157–162.
Nikko, E., and Pelham, H.R. (2009). Arrestin-mediated endocytosis of yeast
plasma membrane transporters. Traffic 10, 1856–1867.
Osman, C., Haag, M., Potting, C., Rodenfels, J., Dip, P.V., Wieland, F.T.,
Bru¨gger, B., Westermann, B., and Langer, T. (2009). The genetic interactome
of prohibitins: coordinated control of cardiolipin and phosphatidylethanol-
amine by conserved regulators in mitochondria. J. Cell Biol. 184, 583–596.
Osman, C., Haag, M.,Wieland, F.T., Bru¨gger, B., and Langer, T. (2010). Amito-
chondrial phosphatase required for cardiolipin biosynthesis: the PGP phos-
phatase Gep4. EMBO J. 29, 1976–1987.
Osman, C., Voelker, D.R., and Langer, T. (2011). Making heads or tails of phos-
pholipids in mitochondria. J. Cell Biol. 192, 7–16.
Rand, R.P., and Sengupta, S. (1972). Cardiolipin forms hexagonal structures
with divalent cations. Biochim. Biophys. Acta 255, 484–492.ell Metabolism 17, 709–718, May 7, 2013 ª2013 Elsevier Inc. 717
Cell Metabolism
A CDP-DAG Synthase in MitochondriaShen, H., Heacock, P.N., Clancey, C.J., and Dowhan, W. (1996). The CDS1
gene encoding CDP-diacylglycerol synthase in Saccharomyces cerevisiae is
essential for cell growth. J. Biol. Chem. 271, 789–795.
Sherman, F. (1991). Getting started with yeast. Methods Enzymol. 194, 3–21.
Sparrow, C.P., and Raetz, C.R. (1985). Purification and properties of the mem-
brane-bound CDP-diglyceride synthetase from Escherichia coli. J. Biol. Chem.
260, 12084–12091.
Tamura, Y., Harada, Y., Yamano, K., Watanabe, K., Ishikawa, D., Ohshima, C.,
Nishikawa, S., Yamamoto, H., and Endo, T. (2006). Identification of Tam41
maintaining integrity of the TIM23 protein translocator complex in mitochon-
dria. J. Cell Biol. 174, 631–637.
Tamura, Y., Endo, T., Iijima, M., and Sesaki, H. (2009). Ups1p and Ups2p
antagonistically regulate cardiolipin metabolism in mitochondria. J. Cell Biol.
185, 1029–1045.
Tamura, Y., Iijima, M., and Sesaki, H. (2010). Mdm35p imports Ups proteins
into the mitochondrial intermembrane space by functional complex formation.
EMBO J. 29, 2875–2887.
Tamura, Y., Onguka, O., Itoh, K., Endo, T., Iijima, M., Claypool, S.M., and
Sesaki, H. (2012). Phosphatidylethanolamine biosynthesis in mitochondria:718 Cell Metabolism 17, 709–718, May 7, 2013 ª2013 Elsevier Inc.phosphatidylserine (PS) trafficking is independent of a PS decarboxylase
and intermembrane space proteins UPS1P and UPS2P. J. Biol. Chem. 287,
43961–43971.
Tuller, G., Hrastnik, C., Achleitner, G., Schiefthaler, U., Klein, F., and Daum, G.
(1998). YDL142c encodes cardiolipin synthase (Cls1p) and is non-essential for
aerobic growth of Saccharomyces cerevisiae. FEBS Lett. 421, 15–18.
Vaden, D.L., Gohil, V.M., Gu, Z., and Greenberg, M.L. (2005). Separation of
yeast phospholipids using one-dimensional thin-layer chromatography. Anal.
Biochem. 338, 162–164.
van den Brink-van der Laan, E., Killian, J.A., and de Kruijff, B. (2004).
Nonbilayer lipids affect peripheral and integral membrane proteins via changes
in the lateral pressure profile. Biochim. Biophys. Acta 1666, 275–288.
van Meer, G., Voelker, D.R., and Feigenson, G.W. (2008). Membrane lipids:
where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112–124.
Vance, J.E., and Tasseva, G. (2013). Formation and function of phosphatidyl-
serine and phosphatidylethanolamine in mammalian cells. Biochim. Biophys.
Acta 1831, 543–554.
